4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-068300
Chief Commercial Officer bought 4,000 shares at $24.40 ($97,600)
From the SEC's structured data for this filing
Trades in this filing
Von Seggern Christopher · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-06 | Purchase : show line 1 in the form | +4,000 | $24.40 | $97,600 | 4,000 | D |
| Open-market purchases · 4,000 sh · avg $24.40 · $97,600 | ||||||
Loading xslF345X03/doc4.xml…